April 22, 2020
McKesson Corp. directors will pay $175 million to resolve a derivative action accusing the pharmaceutical distributor's board of failing to enforce a compliance program to catch suspicious orders of opioids, leading to a hefty fine from the U.S. Department of Justice, under a deal approved Wednesday.